New insights into vascular reactivity: From altered structure to neural control

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 5, 1997, Pages 297-304

  Angus, James A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

acetylcholine; angiogenesis; blood vessel; calcium channels; collaterals; endothelium; hypertension; neuropeptide Y; reactivity

Indexed keywords

ACETYLCHOLINE; CALCIUM CHANNEL BLOCKING AGENT; ENDOTHELIUM DERIVED RELAXING FACTOR; GR 231118; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NITRIC OXIDE SYNTHASE; OMEGA CONOTOXIN GVIA; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; DRUG MECHANISM; ENDOTHELIUM INJURY; FEMORAL ARTERY; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROMODULATION; NEUROTRANSMITTER RELEASE; RABBIT; SUPERFICIAL FEMORAL ARTERY;

EID: 0030976187     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb01191.x     Document Type: Article

References (27)

1. Furchgott RF, Zawadski JV. The obligatory role or endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
2. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarising factors. Circ: Res. 1996; 78: 415-23.
3. Angus JA, Campbell GR, Cocks TM, Manderson JA. Vasodilatation by acelylcholine is endothelium-dependent: A study by sonomicrometry in canine femoral artery in vivo. J. Physiol. 1983; 344: 209-22.
4. Cocks TM, Manderson JA, Mosse PR, Campbell GR, Angus JA. Development of a large fibromusculur intimai thickening does not impair endothelium-dependent relaxation in the rabbit carotid artery. Blood Vessels 1987; 24: 192-200.
5. Angus JA, Cocks TM, Wright CE, Satoh K, Campbell GR. Endothelium-dependent responses in large arteries and in the microcirculation. In: Vanhoutte PM (ed.). Relaxing and Contracting Factors. Humana Press, New Jersey. 1988; 136-87.
6. Angus JA, Ward JE, Smolich JJ, McPherson GA. Reactivity of canine isolated epicardial collateral coronary arteries: Relation to vessel structure. Cire: Res. 1991; 69: 1340-52.
7. Ward JE, Angus JA. Collateral development and angiogenesis after major artery ligation does not alter hindquarter vascular reactivity in conscious rabbits. J. Cardiovase. Pharmacol. 1995; 26: 96-106.
8. Angus JA. Role of the endothelium in the genesis of cardiovascular disease. Clin. Exp. Pharmacol. Physiol. 1996; 23 (Suppl. 1): S16-22.
9. Angus JA, Lew MJ. Interpretation of the acctylcholine test of endothelial cell dysfunction in hypertension. J. Hypertens. 1992; 10 (Suppl. 7): S179-86.
10. Wright CE, Angus JA. Effect of hypertension and hypercholesterolemia on vasodilatation in the rabbit. Hypertension 1986; 8: 361-71.
11. Creager MA, Cooke JP, Mendelson ME et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolaemic humans. J. Clin. Invest. 1990; 86: 228-34.
12. Wright CE, Angus JA, Korner PI. Vascular amplifier properties in renovascular hypertension in conscious rabbits. Hindquarter responses to constrictor and dilator stimuli. Hypertension 1987; 9: 122-31.
13. Korner PI, Angus JA. Structural determinants of vascular resistance properties in hypertension. Hemodynamic and model analysis. J. Vase. Res. 1992; 29: 293-312.
14. Angus JA, Dyke AC. Jennings GL et al. Release of endothelium-derived relaxing factor from resistance arteries in hypertension. Kidney Int. 1992; 41 (Suppl. 37): S73-8.
15. Angus JA, Ferrier CP, Sudhir K. Kaye DM, Jennings GL. Impaired contraction and relaxation in skin resistance arteries from patients with congestive heart failure. Cardiovase. Res. 1993; 27: 204-10.
16. Zelis R, Hayoz D, Drexler H et al. Arterial dilatory reserve in congestive heart failure. J. Hypertens. 1992; 10 (Suppl.): S65-7.
17. McCleskey EW, Fox AP, Feldman DH et al. ω-Conotoxin direct and persistent blockade of specific types of calcium channels in neurons but not muscle. Proc. Natl Acad. Sci. USA 1987; 84: 4327-31.
18. Pruneau D, Angus JA. ω-Conotoxin GVIA is a potent inhibitor of sympathetic neurogenic responses in rat small mesenteric arteries. Br. J. Pharmacol. 1990; 100: 180-4.
19. Pruneau D, Angus JA. Apparent vascular to cardiac sympatholytic selectivity of ω-conotoxin GVIA in the pithed rat. Eur. J. Pharmacol. 1990; 184: 127-33.
20. Whorlow SL, Angus JA, Wright CE. Selectivity of ω-conotoxin GVIA for N-type calcium channels in rat isolated small mesenteric arteries. Clin. Exp. Pharmacol. Physiol. 1996; 23: 16-21.
21. Wright CE, Angus JA. Effects of N-, P- and Q-type neuronal calcium channel antagonist on mammalian peripheral neurotransmission. Br. J. Pharmacol. 1996; 119: 49-56.
22. Pruneau D, Angus JA. ω-Conotoxin GVIA, the N-type calcium channel inhibitor, is sympatholytic but not vagolytic: Consequences for hemodynamics and autonomic reflexes in conscious rabbits. J. Cardiovase. Pharmacol. 1990; 16: 675-80.
23. Hawkes AL, Angus JA, Wright CE. ω-Conotoxin GVIA and prazosin, but not felodipine. cause postural hypotension in rabbits. Clin. Exp. Pharmacol. Physiol. 1995; 22: 711-16.
24. Gibbs WW. A new way to spell relief: V e n o m. Sci. Am. 1996; 274: 21-2 (Editorial).
25. Daniels AJ, Matthews JE, Slepetis R et al. High-affinity neuropeptide Y receptor antagonists. Proc. Natl Acad. Sci. USA 1995; 92: 9067-71.
26. 1 receptors). Br. J. Pharmacol. 1996; 117: 1768-72.
27. 2+ channel blockade with ω-conotoxin GVIA in conscious normotensive and hypertensive rabbits. J. Cardiovase. Pharmacol. 1995; 25: 459-68.